Chugai Pharmaceutical Co., Ltd. (CHGCF) Stock Competitors & Peer Comparison
See (CHGCF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHGCF | $47.65 | +3.52% | 78.4B | 28.88 | $1.65 | +3.79% |
| BMYMP | $400.00 | -57.46% | 814.6B | 1777.78 | $0.23 | +4.56% |
| RHHVF | $411.25 | -2.70% | 327.4B | 20.21 | $20.35 | +3.02% |
| RHHBF | $411.22 | -2.38% | 327.3B | 20.10 | $20.46 | +3.02% |
| RHHBY | $49.06 | -0.02% | 315.9B | 19.16 | $2.56 | +3.15% |
| AZNCF | $189.90 | -1.35% | 294.4B | 31.49 | $6.03 | +1.41% |
| NVSEF | $144.14 | -0.25% | 275B | 20.65 | $6.98 | +3.29% |
| SNYNF | $86.61 | +3.14% | 104.1B | 18.79 | $4.61 | +5.59% |
| GLAXF | $23.54 | -9.46% | 94.4B | 12.32 | $1.91 | +3.81% |
| CHGCY | $23.16 | -2.91% | 76.2B | 27.90 | $0.83 | +3.55% |
Stock Comparison
CHGCF vs BMYMP Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, BMYMP has a market cap of 814.6B. Regarding current trading prices, CHGCF is priced at $47.65, while BMYMP trades at $400.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas BMYMP's P/E ratio is 1777.78. In terms of profitability, CHGCF's ROE is +0.23%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, CHGCF is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check BMYMP's competition here
CHGCF vs RHHVF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, RHHVF has a market cap of 327.4B. Regarding current trading prices, CHGCF is priced at $47.65, while RHHVF trades at $411.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas RHHVF's P/E ratio is 20.21. In terms of profitability, CHGCF's ROE is +0.23%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, CHGCF is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check RHHVF's competition here
CHGCF vs RHHBF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, RHHBF has a market cap of 327.3B. Regarding current trading prices, CHGCF is priced at $47.65, while RHHBF trades at $411.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas RHHBF's P/E ratio is 20.10. In terms of profitability, CHGCF's ROE is +0.23%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, CHGCF is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check RHHBF's competition here
CHGCF vs RHHBY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, RHHBY has a market cap of 315.9B. Regarding current trading prices, CHGCF is priced at $47.65, while RHHBY trades at $49.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas RHHBY's P/E ratio is 19.16. In terms of profitability, CHGCF's ROE is +0.23%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, CHGCF is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check RHHBY's competition here
CHGCF vs AZNCF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, AZNCF has a market cap of 294.4B. Regarding current trading prices, CHGCF is priced at $47.65, while AZNCF trades at $189.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas AZNCF's P/E ratio is 31.49. In terms of profitability, CHGCF's ROE is +0.23%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, CHGCF is more volatile compared to AZNCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check AZNCF's competition here
CHGCF vs NVSEF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, NVSEF has a market cap of 275B. Regarding current trading prices, CHGCF is priced at $47.65, while NVSEF trades at $144.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas NVSEF's P/E ratio is 20.65. In terms of profitability, CHGCF's ROE is +0.23%, compared to NVSEF's ROE of +0.32%. Regarding short-term risk, CHGCF is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check NVSEF's competition here
CHGCF vs SNYNF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, SNYNF has a market cap of 104.1B. Regarding current trading prices, CHGCF is priced at $47.65, while SNYNF trades at $86.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas SNYNF's P/E ratio is 18.79. In terms of profitability, CHGCF's ROE is +0.23%, compared to SNYNF's ROE of +0.14%. Regarding short-term risk, CHGCF is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check SNYNF's competition here
CHGCF vs GLAXF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, GLAXF has a market cap of 94.4B. Regarding current trading prices, CHGCF is priced at $47.65, while GLAXF trades at $23.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas GLAXF's P/E ratio is 12.32. In terms of profitability, CHGCF's ROE is +0.23%, compared to GLAXF's ROE of +0.33%. Regarding short-term risk, CHGCF is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check GLAXF's competition here
CHGCF vs CHGCY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, CHGCY has a market cap of 76.2B. Regarding current trading prices, CHGCF is priced at $47.65, while CHGCY trades at $23.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas CHGCY's P/E ratio is 27.90. In terms of profitability, CHGCF's ROE is +0.23%, compared to CHGCY's ROE of +0.24%. Regarding short-term risk, CHGCF is more volatile compared to CHGCY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check CHGCY's competition here
CHGCF vs BAYRY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, BAYRY has a market cap of 39.1B. Regarding current trading prices, CHGCF is priced at $47.65, while BAYRY trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas BAYRY's P/E ratio is -15.53. In terms of profitability, CHGCF's ROE is +0.23%, compared to BAYRY's ROE of -0.07%. Regarding short-term risk, CHGCF is more volatile compared to BAYRY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check BAYRY's competition here
CHGCF vs OTSKY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, OTSKY has a market cap of 36.5B. Regarding current trading prices, CHGCF is priced at $47.65, while OTSKY trades at $34.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas OTSKY's P/E ratio is 16.09. In terms of profitability, CHGCF's ROE is +0.23%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, CHGCF is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check OTSKY's competition here
CHGCF vs OTSKF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, OTSKF has a market cap of 34B. Regarding current trading prices, CHGCF is priced at $47.65, while OTSKF trades at $64.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas OTSKF's P/E ratio is 15.05. In terms of profitability, CHGCF's ROE is +0.23%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, CHGCF is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check OTSKF's competition here
CHGCF vs DSNKY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, DSNKY has a market cap of 28.1B. Regarding current trading prices, CHGCF is priced at $47.65, while DSNKY trades at $15.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas DSNKY's P/E ratio is 17.52. In terms of profitability, CHGCF's ROE is +0.23%, compared to DSNKY's ROE of +0.16%. Regarding short-term risk, CHGCF is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check DSNKY's competition here
CHGCF vs DSKYF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, DSKYF has a market cap of 27.9B. Regarding current trading prices, CHGCF is priced at $47.65, while DSKYF trades at $15.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas DSKYF's P/E ratio is 17.45. In terms of profitability, CHGCF's ROE is +0.23%, compared to DSKYF's ROE of +0.16%. Regarding short-term risk, CHGCF is more volatile compared to DSKYF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check DSKYF's competition here
CHGCF vs ALPMY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, ALPMY has a market cap of 24B. Regarding current trading prices, CHGCF is priced at $47.65, while ALPMY trades at $13.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas ALPMY's P/E ratio is 13.14. In terms of profitability, CHGCF's ROE is +0.23%, compared to ALPMY's ROE of +0.18%. Regarding short-term risk, CHGCF is more volatile compared to ALPMY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check ALPMY's competition here
CHGCF vs ALPMF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, ALPMF has a market cap of 23.7B. Regarding current trading prices, CHGCF is priced at $47.65, while ALPMF trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas ALPMF's P/E ratio is 12.99. In terms of profitability, CHGCF's ROE is +0.23%, compared to ALPMF's ROE of +0.17%. Regarding short-term risk, CHGCF is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check ALPMF's competition here
CHGCF vs ORINY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, ORINY has a market cap of 21.4B. Regarding current trading prices, CHGCF is priced at $47.65, while ORINY trades at $37.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas ORINY's P/E ratio is 17.35. In terms of profitability, CHGCF's ROE is +0.23%, compared to ORINY's ROE of +0.49%. Regarding short-term risk, CHGCF is less volatile compared to ORINY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check ORINY's competition here
CHGCF vs GIKLY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, GIKLY has a market cap of 15B. Regarding current trading prices, CHGCF is priced at $47.65, while GIKLY trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas GIKLY's P/E ratio is 15.81. In terms of profitability, CHGCF's ROE is +0.23%, compared to GIKLY's ROE of +0.08%. Regarding short-term risk, CHGCF is more volatile compared to GIKLY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check GIKLY's competition here
CHGCF vs RCDTF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, RCDTF has a market cap of 12.2B. Regarding current trading prices, CHGCF is priced at $47.65, while RCDTF trades at $60.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas RCDTF's P/E ratio is 22.81. In terms of profitability, CHGCF's ROE is +0.23%, compared to RCDTF's ROE of +0.24%. Regarding short-term risk, CHGCF is more volatile compared to RCDTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check RCDTF's competition here
CHGCF vs CHJTF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, CHJTF has a market cap of 12B. Regarding current trading prices, CHGCF is priced at $47.65, while CHJTF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas CHJTF's P/E ratio is 21.00. In terms of profitability, CHGCF's ROE is +0.23%, compared to CHJTF's ROE of +0.05%. Regarding short-term risk, CHGCF is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check CHJTF's competition here
CHGCF vs ORINF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, ORINF has a market cap of 11.7B. Regarding current trading prices, CHGCF is priced at $47.65, while ORINF trades at $82.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas ORINF's P/E ratio is 18.89. In terms of profitability, CHGCF's ROE is +0.23%, compared to ORINF's ROE of +0.49%. Regarding short-term risk, CHGCF is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check ORINF's competition here
CHGCF vs CSPCY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, CSPCY has a market cap of 10.5B. Regarding current trading prices, CHGCF is priced at $47.65, while CSPCY trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas CSPCY's P/E ratio is 18.20. In terms of profitability, CHGCF's ROE is +0.23%, compared to CSPCY's ROE of +0.05%. Regarding short-term risk, CHGCF is more volatile compared to CSPCY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check CSPCY's competition here
CHGCF vs GIFOF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, CHGCF is priced at $47.65, while GIFOF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas GIFOF's P/E ratio is 12.46. In terms of profitability, CHGCF's ROE is +0.23%, compared to GIFOF's ROE of +0.08%. Regarding short-term risk, CHGCF is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check GIFOF's competition here
CHGCF vs GIFLF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, GIFLF has a market cap of 7.6B. Regarding current trading prices, CHGCF is priced at $47.65, while GIFLF trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas GIFLF's P/E ratio is 15.66. In terms of profitability, CHGCF's ROE is +0.23%, compared to GIFLF's ROE of +0.08%. Regarding short-term risk, CHGCF is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check GIFLF's competition here
CHGCF vs KYKOF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, KYKOF has a market cap of 7.6B. Regarding current trading prices, CHGCF is priced at $47.65, while KYKOF trades at $14.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas KYKOF's P/E ratio is 18.03. In terms of profitability, CHGCF's ROE is +0.23%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, CHGCF is less volatile compared to KYKOF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check KYKOF's competition here
CHGCF vs OPHLF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, OPHLF has a market cap of 6.8B. Regarding current trading prices, CHGCF is priced at $47.65, while OPHLF trades at $14.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas OPHLF's P/E ratio is 15.65. In terms of profitability, CHGCF's ROE is +0.23%, compared to OPHLF's ROE of +0.09%. Regarding short-term risk, CHGCF is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check OPHLF's competition here
CHGCF vs OPHLY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, OPHLY has a market cap of 6.2B. Regarding current trading prices, CHGCF is priced at $47.65, while OPHLY trades at $4.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas OPHLY's P/E ratio is 14.26. In terms of profitability, CHGCF's ROE is +0.23%, compared to OPHLY's ROE of +0.09%. Regarding short-term risk, CHGCF is more volatile compared to OPHLY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check OPHLY's competition here
CHGCF vs DPHAY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, CHGCF is priced at $47.65, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, CHGCF's ROE is +0.23%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, CHGCF is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check DPHAY's competition here
CHGCF vs SNPHY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, SNPHY has a market cap of 3.7B. Regarding current trading prices, CHGCF is priced at $47.65, while SNPHY trades at $12.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas SNPHY's P/E ratio is 16.35. In terms of profitability, CHGCF's ROE is +0.23%, compared to SNPHY's ROE of +0.13%. Regarding short-term risk, CHGCF is more volatile compared to SNPHY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check SNPHY's competition here
CHGCF vs SNPHF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, SNPHF has a market cap of 3.5B. Regarding current trading prices, CHGCF is priced at $47.65, while SNPHF trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas SNPHF's P/E ratio is 15.48. In terms of profitability, CHGCF's ROE is +0.23%, compared to SNPHF's ROE of +0.17%. Regarding short-term risk, CHGCF is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check SNPHF's competition here
CHGCF vs VRBCF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, VRBCF has a market cap of 3.4B. Regarding current trading prices, CHGCF is priced at $47.65, while VRBCF trades at $408.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas VRBCF's P/E ratio is 19.46. In terms of profitability, CHGCF's ROE is +0.23%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, CHGCF is less volatile compared to VRBCF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check VRBCF's competition here
CHGCF vs HAWPY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, HAWPY has a market cap of 3B. Regarding current trading prices, CHGCF is priced at $47.65, while HAWPY trades at $53.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas HAWPY's P/E ratio is 14.27. In terms of profitability, CHGCF's ROE is +0.23%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, CHGCF is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check HAWPY's competition here
CHGCF vs HAWPF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, HAWPF has a market cap of 2.7B. Regarding current trading prices, CHGCF is priced at $47.65, while HAWPF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas HAWPF's P/E ratio is 12.77. In terms of profitability, CHGCF's ROE is +0.23%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, CHGCF is less volatile compared to HAWPF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check HAWPF's competition here
CHGCF vs PTKFF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, PTKFF has a market cap of 2B. Regarding current trading prices, CHGCF is priced at $47.65, while PTKFF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas PTKFF's P/E ratio is N/A. In terms of profitability, CHGCF's ROE is +0.23%, compared to PTKFF's ROE of +0.16%. Regarding short-term risk, CHGCF is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check PTKFF's competition here
CHGCF vs LYPHF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, LYPHF has a market cap of 1.3B. Regarding current trading prices, CHGCF is priced at $47.65, while LYPHF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas LYPHF's P/E ratio is 16.39. In terms of profitability, CHGCF's ROE is +0.23%, compared to LYPHF's ROE of +0.04%. Regarding short-term risk, CHGCF is less volatile compared to LYPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check LYPHF's competition here
CHGCF vs TGRNF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, TGRNF has a market cap of 633.9M. Regarding current trading prices, CHGCF is priced at $47.65, while TGRNF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas TGRNF's P/E ratio is 9.90. In terms of profitability, CHGCF's ROE is +0.23%, compared to TGRNF's ROE of +0.05%. Regarding short-term risk, CHGCF is more volatile compared to TGRNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check TGRNF's competition here
CHGCF vs JCRRF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, JCRRF has a market cap of 383.7M. Regarding current trading prices, CHGCF is priced at $47.65, while JCRRF trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas JCRRF's P/E ratio is 28.59. In terms of profitability, CHGCF's ROE is +0.23%, compared to JCRRF's ROE of +0.06%. Regarding short-term risk, CHGCF is less volatile compared to JCRRF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check JCRRF's competition here
CHGCF vs MAYNF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, MAYNF has a market cap of 130M. Regarding current trading prices, CHGCF is priced at $47.65, while MAYNF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas MAYNF's P/E ratio is -2.16. In terms of profitability, CHGCF's ROE is +0.23%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, CHGCF is more volatile compared to MAYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check MAYNF's competition here
CHGCF vs PTKFY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, PTKFY has a market cap of 9.7M. Regarding current trading prices, CHGCF is priced at $47.65, while PTKFY trades at $8.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas PTKFY's P/E ratio is 9.64. In terms of profitability, CHGCF's ROE is +0.23%, compared to PTKFY's ROE of +0.16%. Regarding short-term risk, CHGCF is less volatile compared to PTKFY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check PTKFY's competition here
CHGCF vs PSYGF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, PSYGF has a market cap of 2M. Regarding current trading prices, CHGCF is priced at $47.65, while PSYGF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas PSYGF's P/E ratio is -0.17. In terms of profitability, CHGCF's ROE is +0.23%, compared to PSYGF's ROE of -14.36%. Regarding short-term risk, CHGCF is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check PSYGF's competition here
CHGCF vs CRXTQ Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 78.4B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, CHGCF is priced at $47.65, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 28.88, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, CHGCF's ROE is +0.23%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, CHGCF is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check CRXTQ's competition here